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ABSTRACT
DNA glycosylases from the Fpg/Nei structural su-
perfamily are base excision repair enzymes involved
in the removal of a wide variety of mutagen and
potentially lethal oxidized purines and pyrimidines.
Although involved in genome stability, the recent
discovery of synthetic lethal relationships between
DNA glycosylases and other pathways highlights
the potential of DNA glycosylase inhibitors for fu-
ture medicinal chemistry development in cancer ther-
apy. By combining biochemical and structural ap-
proaches, the physical target of 2-thioxanthine (2TX),
an uncompetitive inhibitor of Fpg, was identified. 2TX
interacts with the zinc finger (ZnF) DNA binding do-
main of the enzyme. This explains why the zincless
hNEIL1 enzyme is resistant to 2TX. Crystal structures
of the enzyme bound to DNA in the presence of 2TX
demonstrate that the inhibitor chemically reacts with
cysteine thiolates of ZnF and induces the loss of zinc.
The molecular mechanism by which 2TX inhibits Fpg
may be generalized to all prokaryote and eukaryote
ZnF-containing Fpg/Nei-DNA glycosylases. Cell ex-
periments show that 2TX can operate in cellulo on the
human Fpg/Nei DNA glycosylases. The atomic eluci-
dation of the determinants for the interaction of 2TX
to Fpg provides the foundation for the future design
and synthesis of new inhibitors with high efficiency
and selectivity.
INTRODUCTION
Physical and chemical agents from environmental or nor-
mal endogenous metabolism continuously damage DNA.
To prevent the propagation and accumulation of mutations
resulting from DNA damages, cells have evolved numer-
ous DNA damage sensing and repair strategies which con-
tribute to maintaining genome integrity and stability (1).
Difficulties in repairing DNA damage may cause cellular
dysfunction and death and can also potentially yield un-
controlled cell growth and cancer. Among repair strategies,
the base excision repair (BER) pathway is the major line
of defense against the deleterious effects of oxidized, alky-
lated and lost DNA bases (2,3). DNA glycosylases initiate
the BER pathway by specifically recognizing and removing
the base damage. Although these enzymes can be mono-
functional by hydrolyzing the N-glycosidic bond using a wa-
ter molecule (glycosylase) or bi-functional by using a reac-
tive amine as nucleophile (glycosylase/lyase), they can be
classified in six superfamilies according to their 3D folds,
irrespective of their substrate specificities: the uracil-DNA
glycosylase (UDG), the helix-hairpin-helix (HhH/GPD),
the Fpg/Nei glycosylase, the alkyladenine-DNA glycosy-
lase (AAG), the HEAT-like repeat (HLR) and the T4 en-
donuclease V structural superfamilies (4).
The Fpg/Nei superfamily (also called H2TH superfam-
ily) includes bi-functional enzymes able to remove a wide
variety of oxidized bases (3,5). The enzyme architecture
consists in two globular domains connected by a flexible
hinge: (i) a N-terminal domain rich in -structures con-
taining a highly conserved N-terminal -helix (A) display-
ing generally a proline (P1) at the N-terminal involved in
catalysis and (ii) a C-terminal domain rich in -structures
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containing both DNA binding domains of the enzyme (the
H2TH motif and a -hairpin domain structured in most
cases as a Zinc finger, Supplementary Figure S1). All these
enzymes feature AP lyase activity consisting in the succes-
sive cleavage at the 3’ and then at the 5’ sides of the aba-
sic (AP) site according to ,-elimination. This yields a one
nucleoside gap in DNA. After the action of 3’-phosphatase,
the gap is filled in by a DNA polymerase and the resulting
nick is sealed by a DNA ligase. Regarding substrate speci-
ficity, Fpg/Nei DNA glycosylases can be subdivided in two
groups: (i) the Fpg proteins found in bacteria rather specific
for oxidized purines such as 8-oxoguanine (8-oxoG) and the
imidazole-ring opened purine (FapyG) and (ii) the Nei pro-
teins found in bacteria and eukaryotes rather specific for
oxidized pyrimidines in single- and double-stranded DNA
such as thymine glycol (Tg), 5-hydroxycytosine (5OHC) and
5-hydroxy-5-methyhydantoin (Hyd) (6,7).
Although BER contributes to genome stability, there
are synthetic lethal situations in which the inhibition of
BER enzymes appeared a relevant strategy for cancer ther-
apy. For example, PARP1 (a key BER/SSBR enzyme)
inhibitors seem promising in a therapeutic approach to
treating BRCA1/2- or PTEN-deficient tumors (deficiency
in homologous recombination) (8,9). Otherwise, siRNA-
mediated DNA glycosylase depletion in the osteosarcoma
cell line (including the H2TH DNA glycosylase NEIL1) in-
creases the cytotoxicity of chemotherapeutic agents (10).
The functional depletion of NEIL1 also appears to be syn-
thetic lethal with the depletion of Fanconi anemia DNA
repair pathway (11). In another work, it has been shown
that knockdown of the G:T mismatch-specific thymine-
DNA glycosylase (MBD4) reverses methylation at specific
loci which results in blocking breast cancer metastasis (12).
Thus, selective inhibitors for MBD4 can be useful to prevent
cancer metastasis. In a more recent study, Ramdzan et al.
proposed a new mechanism to sustain proliferation in RAS-
transformed cells through increased BER capability (13). In
such a mechanism, the stimulation of the DNA glycosylase
hOgg1 involved in the excision of the mutagenic 8-oxoG can
be an alternative for RAS-transformed cells to overcome the
antiproliferative effects of excessive oxidative DNA dam-
age. These recent discoveries may provide new therapeutic
windows in cancer therapy that could be exploited with se-
lective drugs that specifically target DNA glycosylases.
In a previous work, we initiated this research by ex-
ploiting the mechanism of the flip out of the damaged
nucleoside-containing DNA and its extrahelical recognition
inside the substrate binding pocket in an attempt to target
the active site of the Escherichia coli Fpg protein (14). Be-
cause of the broad substrate specificity of Fpg, we screened
2,4,5,6-substituted pyrimidines and 2,6-substituted purines
for their ability to inhibit the enzyme. 2-Thioxanthine (2TX,
Figure 1a), one of the thiopurine analogues tested, prove
to be the most efficient inhibitor of the excision of 2,6-
diamino-4-hydroxy-5N-methyl-formamidopyrimidine (N7-
Me-FapyG) by Fpg (14). Surprisingly, the inhibition mode
of 2TX was determined as uncompetitive instead of the ex-
pected competitive mode. This suggested that 2TX binds to
the enzyme/DNA complex outside the active site. By com-
bining X-ray structure and functional studies on both Fpg




































































Figure 1. Inhibition of LlFpg by 2TX. (a) Structures of free nucleobases
used in these experiments. Abbreviations are G for guanine, X for xanthine,
2TX for 2-thioxanthine, 8-oxoG for 7,8-dihydro-8-oxoguanine and FapyG
for 2,6-diamino-4-hydroxy-5-formamidopyrimidine. (b) Effect of free nu-
cleobases on Fpg 8-oxoG-DNA glycosylase activity. 25 nM of 24-mer 8-
oxoG-DNA (Supplementary Table S1) and 5 nM of LlFpg were incubated
30 min at 37◦C with 0, 25, 50, 100, 150, 200, 250 M of G, X, 2TX, 8-oxoG
or FapyG as indicated. Remaining activity (%) was plotted as a function of
free nucleobase concentration. Each point corresponds to the mean value
extracted from at least three independent experiments.
cipher at the atomic level the molecular basis of the mech-
anism by which the enzymes of this class are inhibited by
2TX.
MATERIALS AND METHODS
Chemical, proteins and DNAs
PAR reagent, guanine, xanthine were purchased from
Sigma-Aldrich. 2TX was synthetized as described pre-
viously (14). The recombinant plasmid pFlag-CTC-WT-
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LlFpg encoding for the wt-LlFpg derived from the pFlag-
CTC expression vector (15) and was used to generate single-
point mutations W179A, R247G, C248GH and C268H.
wt LlFpg and R247G and C168GH variants were overex-
pressed in E. coli BH540 (fpg mutY) strain and purified to
homogeneity as already described for the wild-type enzyme.
Other H2TH-DNA glycosylases were overexpressed with a
C-terminal 6His-Tag in BL21(DE3) strain using the recom-
binant vectors derived from pET22b and pET30a for EcNei
and hNEIL1, respectively (plasmids are gifts from Drs Su-
sannWallace and Sylvie Doublié). EcNei and hNEIL1 were
purified as already described (16,17). The 6His-hNEIL2 fu-
sion protein was overproduced in E. coli BL21CodonsPlus
cells using the expression vector pPR363 (a gift from Juan
Pablo Radicella) and purified as previously described (18).
Unmodified, THF- and 5OHC-containing single-stranded
oligonucleotides were purchased from Eurogentec. Modi-
fied oligonucleotides containing Hyd and Bz-cFapyG were
synthetized and purified as previously described (15,19,20).
The structure of the damaged nucleosides and oligonu-
cleotide sequences are reported in Supplementary Figure
S2.
Enzyme assays
For DNA binding experiments (electrophoresis mobility
shift assay, EMSA) and DNA cleavage (glysosylase/lyase)
assays, the damaged strands (containing either THF, Hyd,
8-oxoG or 5-OHC, Supplementary Figure S2) were 5’-[32P]-
labeled before annealing with its complementary strand as
previously described. Assays were performed in standard
experimental conditions (21,22) except that all incubation
mixtures contained 8% final concentration of dimethyl sul-
foxide (DMSO) required for solubilizing the nucleobases
(G, 8-oxoG, FapyG, X and 2TX, Supplementary Figure
S1a). After electrophoresis, gels were exposed to autoradio-
graphy; scanned using STORM-Imager and quantified us-
ing ImageQuant software.
Crystallization, X-ray diffraction data collection and struc-
ture determination
Protein/DNA complexes were obtained by mixing in a 1/1
molar ratio wt LlFpg, R247G or C248GH with a 14-mer
DNA duplex containing either THF or Bz-cFapyG at a final
concentration in protein of 2–5 mg/ml as already described
(15,23,24). Crystals of R247G and C248GH bound to 14-
mer THF-DNA were obtained in the conditions already de-
scribed for the wt LlFpg. wt LlFpg/DNA complexes treated
by 2TX were obtained by mixing one volume of the com-
plex with one volume of a 2TX-saturated solution contain-
ing 0.1 M Hepes-NaOH, pH7.6, 1.2–1.4 M sodium citrate,
0.1–0.5% DMSO. The resulting drop was immediately equi-
librated against the same solution by using the hanging drop
vapor diffusion method. Usually, crystals appear after 2–3
days at 20◦C and grow for 1–2 weeks.
Crystals were flash cooled in liquid nitrogen in the mother
liquor. X-ray diffraction data were collected at 100K at
beamline PROXIMA-1 (SOLEIL, Paris) or ID23–1 (ESRF,
Grenoble). All data were processed using the XDS package
(25) and the CCP4 program SCALA (26,27). The 3D struc-
tures were solved by molecular replacement using PHASER
(28) and complexes previously reported by us (PDB code
1PM5 and 3C58) as search models. Atomic models were
then refined using phenix.refine (29) and manually im-
proved using COOT (30). Data collection and refinement
statistics are listed in Supplementary Table S1. All structure
figures were generated with CCP4MG (31).
PAR assay
Essays were performed at room temperature in 200 l final
volume in 25 mM Hepes/KOH, pH7.5, 70 mM KCl, 5%
glycerol, 8% DMSO containing 5 M of enzyme (LlFpg,
EcNei, hNEIL1, hNEL2 or available purified LlFpg mu-
tant versions), 100 M of 4-(2-pyridylazo)resorcinol (PAR)
with or without 7.5 M of 14-mer THF-containing DNA
duplex and an excess of 10 mM of 2TX. In the presence of
DNA, the mixture containing the enzyme, the PAR reagent
and DNA were first pre-incubated at room temperature for
20 min to allow formation of the enzyme-DNA complex
before 2TX addition. The release and re-sequestration of
Zn ion was calorimetrically measured in the chelate form
[Zn2+-PAR] at max 500 nm. Re-sequestration of Zn2+ by
the PAR chelate was determined from a standard solution
of ZnSO4. Data were presented as molar ratios of release
(re-sequestered) Zn2+ to enzyme in percent. All titrations
were performed in triplicate and data were averaged.
Effect of 2TX and X on the 5OHC-DNA glycosylase activity
of K21 cells
The Human fibroblast cell line K21 immortalized with
hTERT (32) was a kind gift from Prof. M.H.K. Linskens,
University of Groningen, The Netherlands. Cells were
cultured in F10 Medium (+L-glutamine, Gibco), supple-
mented with 10% fetal bovine serum (Gibco) and grown at
37oC in 5% CO2 in 100 mm cell culture dishes.
Cells at 90% confluence (3–4 ml cells per dish) were
washed with 1× PBS and serum-free medium containing
different doses of 2-thioxanthine (2TX) or xanthine (X)
(0, 200, 500, 1000 M). After 6 h of treatment, cells were
washed with 1× PBS and then scraped into a 250 l of cold
Sonication Buffer (25 mM Tris-HCl, pH 7.5; 25 mM NaCl;
2 mM EDTA; 10% glycerol; 1× protease inhibitors cocktail
– Roche). Next, cells were transferred to the ice chilled tubes
and sonicated at the ‘High’ mode of the Bioruptor (Diagen-
ode) sonicator. Three rounds of 15 s sonication and 30 s of
break between the following pulses were done. Cell lysates
were centrifuged (4000 g, 5 min) and the supernatants (cell-
free extract) aliquoted and immediately frozen in liquid ni-
trogen and stored at –80◦C. 5OHC-DNA glycosylase activ-
ity contained in the cell-free extracts was measured by using
5’-[32P]-34-mer 5OHC-DNA duplex as a substrate (Supple-
mentary Figure S2). Note that 0.25 pmole of radiolabeled
DNA probe was incubated for 1 h at 37◦C with 20 g of pro-
tein from the free K21 cell extracts in 30 l in reaction buffer
(25 mM Tris-HCl, pH 7.6; 25 mM NaCl; 2 mM ethylene-
diaminetetraacetic acid (EDTA)). Subsequently, proteins
were digested for 1 h with Proteinase K (Sigma) (0.2 g/l
of reaction mixture), and cleavage of the AP site gener-
ated by DNA glycosylases was performed by incubation
with 0.2 N NaOH for 15 min at 65◦C. Reaction mixtures






Nucleic Acids Research, 2014, Vol. 42, No. 16 10751
were next neutralized with equimolar HCl and stopped by
the addition of 25 l of 95% formamide, 20 mM EDTA,
0.05% xylene cyanole and 0.05% bromophenol blue. DNA
reaction products were then separated by 20% polyacry-
lamide gel (7M Urea) electrophoresis. Gels were exposed to
a phosphoimager screen which subsequently was scanned.
Radioactive bands were visualized with FujiFilm FLA7000
software. Intensities of bands were calculated with Multi-
Gauge software.
Viability of K21 cells after 2TX and X treatment
About 1000 cells were seeded to each well of 96-well plate
and incubated for 16 h to enable cell adhesion. Then cells
were washed with 1× PBS and serum-free medium contain-
ing different doses of 2TX and X in DMSO (0, 200, 500,
1000 M) or DMSO alone was added. Cells were further
incubated for 6 h at 37o C in 5% CO2 atmosphere. Sub-
sequently, fresh medium with AlamarBlue was added and
after further overnight incubation at 37o C in 5% CO2 flu-
orescence of living cells was measured at 540 nm/590 nm.
Cell viability was calculated as a percent of untreated cells
survival in the presence of DMSO alone.
Mutagenesis experiments
The in vivo functionality of the LlFpg variants (W179A,
R247G, C248GH and C268H) as compared to that of wt
LlFpg was estimated by their abilities to complement the
spontaneous mutator phenotype of the E. coli fpg mutY
double mutant BH990 (derived from JM105). In practice,
the frequency of rifampicine-resistant cells in 11 indepen-
dent cultures was determined for BH990 cells expressing
the wt or variants LlFpg proteins (33). Each protein was
expressed in BH990 using the recombinant vectors pFlag-
CTC (see above).
RESULTS AND DISCUSSION
Zinc finger of the Fpg protein is one of the targets of 2TX:
evidence from crystal structures
The Fpg protein from Lactococcus lactis (LlFpg) (34) was
our Fpg model for X-ray structure investigations. We first
examined the effect of 2TX and other free purines on LlFpg
8-oxoG-DNA glycosylase activity (Figuer 1a). The excision
of 8-oxoG from 24-mer DNA duplex (Supplementary Fig-
ure S2) by LlFpg was inhibited by increased 2TX concen-
trations (red curve, Figure 1b). The inhibition appears spe-
cific since the most canonical free nucleobase products of
the enzyme (8-oxoG and FapyG) and the natural free nucle-
opurine (G) had no effect (green, magenta and black curves,
respectively; Figure 1b). Although it is commonly accepted
that damaged nucleobase products of Fpg do not inhibit en-
zyme activity, it has been shown that the free nucleotide 8-
oxodGMP is able to inhibit EcFpg with Ki = 700 M (35).
Binding of 8-oxoG nucleoside inside the active site has been
also reported in the crystal structure of Ogg1 from Clostrid-
ium acetobutylicum (36). The possible transient confinement
of the free damaged nucleobase product within the active
site has been already observed for other DNA glycosylases,
such as hOgg1 (37). Thus, the free 8-oxoG base may be re-
tained by hOgg1 (the human Fpg functional homologue) in
the substrate recognition site after N-glycosidic bond cleav-
age. This results in retro-inhibition of the enzyme activity
by decreasing its turnover and the lyase activity (38). Un-
ambiguously, such inhibition by free 8-oxoG does not op-
erate on the Fpg protein (green curve, Figure 1b). Interest-
ingly, xanthine (X) which diverges from 2TX by only the
nature of the substitution on position 2 (an oxo-group in-
stead of a thione-group, Figure 1a), does not affect Fpg
activity (blue curve, Figure 1b) suggesting that the thione-
group of 2TX may be involved in the Fpg inhibition mech-
anism. The previous observation showing that other thio-
nucleopurines and -pyrimidines have no effect on Fpg activ-
ity (14) suggests that the xanthine-moiety of 2TX combined
with the 2-thione group jointly contribute to the inhibition.
Overall, these data indicate that 2TX inhibits Fpg whatever
its bacterial origin, E. coli or L. lactis ((14), Figure 1b).
To elucidate the structural basis of the enzyme inhibition
by 2TX, stable complexes of wt-LlFpg bound to substrate
analog-containing DNA were crystallized in the presence of
2TX. We obtained crystals with 2TX-treated complexes of
LlFpg bound to tetrahydrofurane (THF)- or the carbanu-
cleoside of N7-Benzyl-FapyG (Bz-cFapyG)-containing 14-
mer DNA duplexes ([WT/THF]-2TX and [WT/Bz]-2TX,
respectively) (Supplementary Figure S2). The 3D struc-
tures of both complexes were solved by molecular replace-
ment using PDB id codes 1PM5 ([WT-/THF]) and 3C58
([WT/Bz]) as searching models and refined to 2.4 and 2.1 Å
resolution, respectively (15,23) (Supplementary Table S1).
Apart from the zinc finger domain of the enzyme (ZnF),
the overall structures of LlFpg/DNA complexes treated by
2TX were very similar to each other and with starting mod-
els without drug (Figure 2). The common and most strik-
ing feature of both structures obtained with 2TX was the
absence of the zinc ion which is associated with a confor-
mational change in the zinc coordination sphere residues
(ZnF cysteines and the peptide S246-A250). In both cases,
the tetrahedral zinc ion initially coordinated by four cys-
teines in 1PM5 and 3C58 (C245, C248, C265 and C268,
Figure 2a) was no longer present (Figure 2b and c). More-
over, most buried cysteines of Fpg-ZnF (Supplementary Ta-
ble S2), Cys245 and Cys265, were covalently linked together
by forming a disulphide bridge.
In the structure of [WT/THF]-2TX, C268 kept the same
conformation as the one observed in the structure of
[WT/THF]. The associated partial structural change from
the N-terminal side of ZnF (the peptide 246–250 including
part of the zinc coordination sphere residues and the start of
the 9-strand, Supplementary Figure S1c) results in expos-
ing the C248 side chain to the solvent as seen in the increase
of accessible surface area from 3.1 Å2 in 1PM5 to 21.4 Å2
in the structure with 2TX (Figure 2a and b, Supplemen-
tary Table S2) (sulfur accessible surface areas were calcu-
lated with POPS, (39)). Additional density near the S atom
of C248 suggested that a 2TX molecule was bound to the
enzyme by a disulfide bond. A 2TX molecule was then mod-
eled in SigmaA-weighted 2mfo-Dfc electron density maps.
Following refinement of the structure of [WT/THF]-2TX
(Supplementary Table S1), the average B-factor of the co-
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Figure 2. X-ray structures of Fpg zinc finger oxidized by 2TX. (a) Native Fpg zinc finger in the crystal structure of LlFpg bound to tetrahydrofurane(THF)-
containing 14-mer DNA duplex (green, 1PM5). (b) and (c) Oxidized Fpg zinc finger in the crystal structure of LlFpg bound to THF- and Bz-cFapyG-
containing DNA after treatment of the preformed protein/DNA complex with 2TX ([WT/THF]-2TX and [WT/Bz]-2TX in blue and magenta, respectively).
(d) 2Fo-Fc Simulated Annealing omit map contoured at 0.7 of [WT/THF]-2TX (in black grid). (e) Phased anomalous difference map contoured at 3.2
of [WT/Bz]-2TX (in light brown grid). (f) View of the binding mode of 2TX to W179 in the crystal structure of [WT/Bz]-2TX. In all views, cysteine thiolates
and disulfide bonds are indicated in yellow sticks. A superimposition of the structures in (a), (b) and (c) is shown in Supplementary Figure S3.
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valently linked 2TX molecule was 88.9Å2 which may re-
sult from partial occupancy and/or multiple conformations
(Figure 2b and d). In addition, some extra density was seen
near the S atom of C268 and might be attributed to the S
atom of a second 2TX molecule bound to this cysteine by a
disulfide bond. Electron density for the other atoms of the
2TX xanthine-moiety was extremely weak and refinement
statistics with a second 2TX molecule bound to Fpg did not
lead to satisfying values. This is certainly due to very low
occupancy and multiple conformations. Therefore, a 2TX
molecule (potentially bound to C268) was omitted from the
last refined model.
Contrary to the structure of [WT/THF]-2TX, a 2TX
molecule covalently bound to C268 was easily modeled
in the electron density map of the crystal structure of
[WT/Bz]-2TX (Figure 2c). In addition, an X-ray diffraction
data set was collected at a wavelength of 1.55Å to exploit
the anomalous signal of S atoms (Supplementary Table S1).
The phased anomalous density map shows unambiguously
the position of S atoms of the modified ‘zincless’ finger (the
disulfide bonds between C245 and C265 and between C268
and 2TX, Figure 2e). Some extra density was also seen near
the S atom of C248 and might be attributed to the S atom of
a 2TX molecule bound to this cysteine by a disulfide bond
(but it was omitted from the last refined model). Interest-
ingly, the xanthine-moiety of the 2TX molecule bound to
C268 makes - stacking interactions with the aromatic
ring of W179 and an H-bond from its N(9) to the carbonyl
O atom of the main chain of the same Fpg residue (Figure
2f).
Structural studies of Fpg/DNA complexes treated by
2TX indicated that 2TX is able to oxidize the zinc finger
of the enzyme (Figure 2 and Supplementary Figure S3).
One of the Fpg targets of 2TX is localized outside the ac-
tive site and thus illustrating the marked uncompetitive com-
ponent of the inhibition (14). Interestingly, the binding of
2TX to W179 and its covalent link to C245 or C268 are
also in good agreement with single-turnover inhibition ex-
periments which suggested that the thione function and the
xanthine ring-moiety of 2TX are both needed for inhibition
(Figure 1). The stacking between the -orbitals of 2TX and
W179 requires the imidazole ring of 2TX and thus can ex-
plain why the thio-pyrimidines tested previously were un-
able to inhibit the enzyme (14). In addition, the H-bond be-
tween N(9) of the imidazole ring of 2TX and the CO back-
bone of W179 observed in the crystal structure suggests that
the N(9) of 2TX is protonated. The N(9)H tautomer of 2TX
is known to co-exist in solution with the N(7)H tautomer
and it was proposed to be the active form for the inhibition
of the E. coli Fpg protein (14,40–42). 3D structures revealed
that 2TX is able to chemically react with the two most ex-
posed cysteines C248 and C268 of Fpg-ZnF (Supplemen-
tary Table S2), resulting in their oxidation and the loss of
the Zn ion. These structural observations highlight a pos-
sible irreversible inhibition process associated with the loss
of Zn2+ in solution.
Figure 3. Time course of 2TX-induced Zn-release from the free and DNA
bound LlFpg. LlFpg or the preformed LlFpg/14-mer THF-DNA com-
plex (Supplementary Figure S2) was incubated at room temperature with
(red and blue curves, respectively) or without (orange and green curves, re-
spectively) 2TX in the presence of PAR. The release of Zn2+ ion contained
in LlFpg induced by 2TX is followed by its re-sequestration by the PAR
reagent which absorbs at 500 nm under its chelated form [PAR]2-Zn2+.
Data (black points) corresponding to the mean values of three independent
kinetics were plotted as a function of time and, when Zn2+ was released,
fitted by applying [Zn2+]release/[LlFpg] = A0. (1-exp(-kobs.t)), where A0 is
the total [Zn2+] extracted from LlFpg (i.e. [Zn2+]release/[LlFpg] = 1), kobs
the observed first-order kinetic constant and t the incubation time.
2TX reacts in solution with both the free and DNA-bound Fpg
protein inducing zinc release and abolishing DNA binding
The common structural feature revealed by crystal struc-
tures of Fpg/DNA complexes treated by 2TX is the oxida-
tion of the enzyme zinc finger (ZnF) associated with the loss
of the zinc ion. To eliminate any bias due to the crystalliza-
tion medium and/or a special chemistry related to the pecu-
liar molecule arrangement in the crystal, it was necessary to
examine the Zn ion extrusion in solution. There is a direct
method for assaying the presence of micromolar concentra-
tions of free Zn(II) ions in solution. This method exploits
differences in the visible absorption spectra of the chro-
mophoric chelator 4-(2-pyridylazo)resorcinol (PAR) after
its complexation with Zn2+ (43). We used the PAR assay to
verify if 2TX can induce the loss of the Zn2+ ion in solution
as suggested by X-ray studies. To examine how DNA modu-
lates the action of 2TX, the experiments were performed in
the presence or in the absence of THF-containing 14-mer
DNA duplex (Supplementary Figure S2). For that LlFpg
alone or bound to THF-DNA were incubated in the pres-
ence of 2TX and PAR reagent. The formation of the PAR-
Zn2+ chelate, attesting the presence of free Zn2+ in solution,
was followed as function of time by its absorption at 500
nm (Figure 3). 2TX is able to extract the Zn ion in solution
from the enzyme bound to DNA (blue curve, Figure 3). In-
terestingly, this experiment also revealed that 2TX induces
Zn loss from the free enzyme (red curve, Figure 3). This sug-
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gests that a non-competitive inhibition mode mediated by
2TX could contribute to the inhibition. In this case, the in-
hibitor binds outside the active site and has an equal affinity
for the enzyme and the enzyme-substrate binary complex.
The difficulty of detecting a possible non-competitive inhi-
bition mode in kinetic experiments (14) can be explained
by assuming that the binding of the enzyme to its DNA
substrate is much faster than the binding of 2TX to the en-
zyme. Consequently in the presence of DNA, 2TX essen-
tially encounters in solution the enzyme bound to its DNA
substrate. In such a situation, it is the uncompetitive inhibi-
tion mode which essentially contributes to the global inhi-
bition observed. Although in the same range of magnitude,
the DNA-bound enzyme appears slightly more sensitive to
2TX (almost 1.6 times) than the free enzyme as indicated
by the apparent Zn-release kinetic constant, kobs (Table 1).
Such a situation indicates that the inhibitor may bind the
free enzyme and the enzyme-substrate complex differently.
We have no structural evidence to explain why the enzyme
bound to DNA is more sensitive to 2TX. Indeed, the Zn-
Cys coordination core of Fpg ZnF appears similarly acces-
sible in both situations. With the exception of some flexible
loops of the enzyme which locally rearrange through bind-
ing, the global fold of the free and bound enzyme does not
change significantly, especially the ZnF core (24). Probably,
the presence of DNA creates a better chemical environment
for 2TX. We surmise that the binding of 2TX is similar in
both situations but that its reactivity against ZnF cysteine
thiolates is increased by the presence of DNA.
Fpg ZnF being one of the DNA binding domains of
the enzyme (H2TH domain, the second one, Supplemen-
tary Figure S1), it can be expected that in solution its ox-
idation by 2TX will significantly impair the enzyme DNA
binding. To provide new insight into this problem, we ana-
lyzed the effect of 2TX on the ability of Fpg to bind specif-
ically to damaged DNAs using an electromobility shift as-
say (EMSA). We exploited here the possibility of the en-
zyme to form abortive and stable complexes with sub-
strate analogue-containing DNAs that we had previously
designed and synthetized for solving the X-ray structures
of Fpg bound to DNA. THF was used as an abasic (AP)
site analogue (Supplementary Figure S2). THF-DNA du-
plex is recognized with a high affinity by LlFpg while be-
ing unable to process them (15,19,44). At first, the effect of
8% DMSO (used to solubilize 2TX) was examined on the
titration of 14-mer THF-DNA by LlFpg (Supplementary
Figure S4). Under the condition used, the concentration of
enzyme needed for half-maximal binding is equal to the ap-
parent dissociation constant (KDapp) of the protein/DNA
complex considered (44). Although in the same range of
magnitude, the presence of DMSO in the reaction mixtures
decreased 3 times KDapp determined for THF-DNA. This
means that DMSO stabilized the enzyme/DNA complex
and/or stimulated the binding property of the enzyme. Such
an effect of DMSO on the stability of nucleoprotein com-
plexes has been already observed and is known to coun-
teract the dissociation effect of salt (45). The effect of in-
creased 2TX concentration (in 8% DMSO) on DNA bind-
ing activity of LlFpg and the stability of LlFpg/DNA com-
plexes was next analyzed (Figure 4). In the same concen-
tration range, 2TX strongly inhibited the DNA binding ac-
Figure 4. 2TX-induced inhibition of LlFpg DNA binding and
LlFpg/DNA dissociation. Protein/DNA complex was analyzed by
EMSA (see Supplementary Figure S4) using as DNA probe the 14-mer
THF-DNA (Supplementary Figure S2). Binding experiments were carried
out with 2 nM LlFpg pre-incubated on ice for 20 min with indicated 2TX
concentrations. After that, DNA was added to the pre-incubation mixture
and incubated for 20 min on ice before EMSA analysis (open circles). The
stability of the Fpg/DNA complex was studied as follows: the enzyme
(2 nM) and DNA (0.1 nM) were first pre-incubated for 20 min on ice.
The resulting pre-formed protein/DNA complex was then incubated for
an additional 20 min on ice with indicated 2TX concentrations (filled
circles). An example of such an experiment is shown in the insert. Data
were normalized to the Fpg/DNA complex observed in the absence of
2TX (about 20–25%, see insert and Supplementary Figure S4). Each
experimental point represents the mean value from three independent
experiments.
tivity of the enzyme (open circle, Figure 4) and induced the
dissociation of the preformed Fpg/DNA complex (filled cir-
cles, Figure 4). As observed above using the PAR assay,
this means that both the free and the bound enzyme are
exposed to the deleterious effect of 2TX. This also sug-
gests that, in solution, the disruption of zinc coordination
in Fpg ZnF by 2TX impairs the DNA binding of the en-
zyme and consequently the enzyme activity. This observa-
tion was not surprising since it has long been known that
the Fpg ZnF integrity is essential for enzyme binding to
its DNA substrate. Indeed, site-directed mutagenesis of cys-
teines belonging to E. coli Fpg ZnF (resulting in point mu-
tations Cys to Gly, Ala, Ser or His) abolishes the enzyme
DNA binding (46–48). In addition, Cys to Gly mutations
affecting Cys residues outside ZnF do not impair catalytic
and DNA binding properties (46,47). The effect of 2TX also
compares well with the observation that non-cytotoxic con-
centrations of cadmium (Cd(II)), nickel (Cu(II)) and mer-
cury (Hg(II)) inhibit Fpg (49). Because all these metals are
known to be exchangeable with Zn(II) of Fpg ZnF (47), it
has been proposed that metal inhibition results in disturb-
ing the native structure of Fpg ZnF and consequently the
Fpg DNA binding and catalysis. Surprisingly, 2TX-induced
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Table 1. Observed kinetic constants for 2TX-induced Zn release of ZnF-containing H2TH DNA glycosylases
Proteins kobs (min-1)a kobs ratiob
- DNA + DNAc
LlFpg WT 0.073 ± 0.001 0.113 ± 0.004 1.55
R247G 0.212 ± 0.005 0.333 ± 0.004 1.57
C248GH 0.045 ± 0.001 0.075 ± 0.001 1.67
EcNei WT 0.296 ± 0.001 0.452 ± 0.002 1.53
hNEIL2 WT 0.180 ± 0.002 0.299 ± 0.003 1.66
a Mean values of three independent experiments (±SD). b kobs ratio = kobs(+DNA)/kobs(-DNA). c 14-mer THF-DNA (Supplementary Figure S2). See also
the caption of Figure 3.
oxidation of Fpg-ZnF did not significantly affect, in the
crystal, the -hairpin structure (9-10) of the DNA bind-
ing domain (Supplementary Figure S1). Especially, the in-
variant Arg260 residue of the 9-10 loop maintains its in-
teractions with both DNA backbone phosphates bordering
the flipped out damaged nucleoside (15,24). The compact-
ness of the resulting ‘zincless’ finger domain observed in
crystal structures is probably maintained partly by the disul-
fide bridge Cys245-S-S-Cys265 (Figure 2) and mainly by the
crystal packing interactions which prevent the domain from
locally unfolding.
2TX is a general inhibitor of zinc finger-containing Fpg/Nei
DNA glycosylases
The inhibition of Fpg by 2TX led us to explore the abil-
ity of this drug to inhibit other Fpg-related enzymes from
the Fpg/Nei structural superfamily. In this aim, we ana-
lyzed the effect of 2TX on the excision of the 5-hydoxy-
5-methylhydantoine (Hyd)-containing 24-mer DNA duplex
by LlFpg, the E. coli Nei protein (EcNei) and the hu-
man Nei-like proteins 1 and 2 (hNEIL1 and hNEIL2) (see
Supplementary Figure S2 for the structure of Hyd). As
previously shown, Hyd-containing single-stranded DNA,
double-stranded DNA with Hyd opposite C and G is a
substrate for hNEIL2, Ec/LlFpg and EcNei/hNEIL1, re-
spectively (22,50). Assays were performed in the presence
of increased concentrations of 2TX (Figure 5a). The Hyd-
DNA glycosylase of LlFpg was inhibited by 2TX (red curve,
Figure 5a) as were the N7-Me-FapyG- (14) and 8-oxoG-
DNA glycosylases (red curve, Figure 1c). This indicates that
2TX inhibits the enzyme whatever the nature of the dam-
aged base-containing DNA substrate considered (oxidized
purines or pyrimidines). The Hyd-DNA glycosylase activ-
ity of EcNei and hNEIL2 were also strongly inhibited by
2TX (blue and green curves, respectively, Figure 5a). As ex-
pected, 2TX did not affect the Hyd-excision by the hNEIL1
protein which contains a finger motif devoid of zinc (black
curve, Figure 5a) (51). This reinforces the structural obser-
vations suggesting that ZnF of these enzymes is the target
for 2TX (see below). As above, we estimated the specificity
of 2TX for Fpg/Nei-DNA glycosylases by comparing its ef-
fect on Hyd-DNA glycosylase with those of other free nu-
cleobases (Supplementary Figure S5). For all the enzymes
considered, G, X, FapyG and 8-oxoG nucleobases had no
significant effect on Hyd-DNA glycosylase (a weak inhibi-
tion by FapyG was observed for EcNei and hNEIL2). Com-
parison between the effect of X and 2TX confirms again
that the thio-function of 2TX plays an essential role in the
enzyme inhibition as suggested above for the inhibition of
the Fpg 8-oxoG-DNA glycosylase (Figure 1c).
The singular character of hNEIL1 resistance against 2TX
inhibition immediately suggests that the binding and reac-
tive site(s) (i.e. ZnF) for 2TX leading to enzyme inhibition
is absent in this protein. Crystal structures of free hNEIL1
and the Mimivirus NEIL1 (mvNei1) bound to DNA reveal
that the global folds of these proteins are very similar to
those of bacterial Fpg/Nei proteins, mvNei2 and human
hNEIL3 (51–55). The peculiarity of NEIL1 orthologs re-
lies on the absence of ZnF (a structural motif present in
most of the other Fpg/Nei DNA Glycosylases) which is re-
placed by a ‘zincless finger’, ZnLF. Both ZnF and ZnLF
domains of Fpg/Nei DNA glycosylases are superimposable
especially in the -hairpin motif level and play the same
role in DNA binding (Supplementary Figure S1). Combin-
ing all these structural and biochemical data, it is reason-
able to conclude that ZnF of Fpg/Nei DNA Glycosylases
is a general target for 2TX. However, with the exception
of LlFpg which contains only 4 cysteines all involved in
Zn coordination, the other Fpg/Nei DNA glycosylases (in-
cluding EcFpg) have additional free cysteines in their pri-
mary structures which could be potentially capable of re-
acting with 2TX. If 2TX is able to react with these free
cysteines, this does not result in enzyme inhibition in par-
ticular for hNEIL1. For EcNei and hNEIL2, it was how-
ever necessary to determine whether 2TX is able to induce
the release of the zinc ion from ZnF in order to confirm
the inhibition mechanism. Unambiguously, the incubation
of 2TX with EcNei and hNEIL2 results in the loss of Zn
(Figure 5b). As for Fpg, the zinc loss is observed for the
protein alone and for the protein/DNA complexes. The ap-
parent kinetic constants for the release/re-sequestration of
Zn(II) are greater when EcNei and hNEIL2 are bound to
DNA (about 1.6 times, Table 1). Although it was difficult
to fully assess whether one enzyme is more sensitive than
the other, 2TX-induced zinc extraction appears more effec-
tive on EcNei and hNEIL2 than on LlFpg (about 4 and 2.5
times, respectively, Table 1). Interestingly, 2TX also inhibits
EcNei and hNEIL2 more effectively than LlFpg in the same
2TX-concentration range (Figure 5a). Thus, there is a di-
rect relationship between the inhibition power of 2TX and
its ability to induce the loss of zinc (i.e. ZnF oxidation).
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Figure 5. 2TX-induced inhibition of zinc finger-containing Fpg/Nei DNA
glycosylases is associated with the loss of Zn2+ ion. (a)Inhibition of Fpg/Nei
Hyd-DNA glycosylase activity by 2TX 1 nM of single- (with 10 M
hNEIL2) or double-stranded 5’-[	32P]-24-mer oligonucleotide containing
5-hydroxy-5-methylhydantoin (Hyd, Supplementary Figure S2) opposite
G (with 7 M EcNei and 8 M hNEIL1) or C (with 5 M LlFpg) were
incubated 30 min at 37◦C in the presence of increased concentrations of
2TX. Incubation mixtures were then analyzed by Urea-PAGE and quan-
tified as described in Materials and Methods section. (b)Time-course of
2TX-induced Zn-release of EcNei and hNEIL2 PAR assays were carried
out as described in Materials and Methods section under the same con-
ditions used in experiments presented in Figure 3. DNA corresponds to
single-stranded 24-mer Hyd and double-stranded 24-mer Hyd:G-DNA for
hNEIL2 and EcNei, respectively (Supplementary Figure S2).
In order to investigate in living cells the possible effect
of 2TX on the repair activity of the human Fpg/Nei DNA
glycosylases, human fibroblasts from the K12 cell line were
treated for 6 h either with 2TX or its analogue xanthine (X),
which did not inhibit repair enzymes in vitro (Figure 1a).
The 5-OHC (5-hydroxycytosine)-DNA glycosylase partly
Figure 6. Effect of 2TX in cellulo. (a) Effect of 2TX and X on the 5-OHC-
DNA glycosylase activity. (b) Effect of 2TX and X on cell survival. Human
fibroblast K21 cells were treated for 6 h with indicated concentrations of
2-thioxanthine (2TX) or xanthine (X). Relative 5-OHC-DNA glycosylase
activity in cell-free extract and cell viability were determined and plotted as
a function of the nucleobase concentration used. Each point corresponds
to the mean value of three independent experiments.
associated with hNEIL2 was measured in cell extracts af-
ter treatment. Incubation of cells with 2TX decreased in a
dose-dependent manner the 5-OHC excision from DNA by
cell-free extracts while X had no effect (red and black curves,
respectively, Figure 6a). Such a decrease of repair was not
associated with 2TX toxicity, since none of the concentra-
tions of 2TX or X used inhibited cell viability (Figure 6b).
These data suggest that 2TX may also inhibit 5-OHC-DNA
glycosylase activity of hNEIL2 in living cells without induc-
ing cell death. The inhibition effect of 2TX appeared in-
complete and reached around 50%. This partial inhibition
was not surprising since DNA glycosylases such as hNTH1
(from the HhH superfamily) and hNEIL1 (insensitive to
2TX in vitro, Figure 5a) have overlapping substrate speci-
ficities and serve as backups for each other (56).
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Proposed mechanism for the inhibition of ZnF Fpg/Nei-DNA
glycosylases by 2TX
The present data suggest that the inhibition of Fpg/Nei-
DNA glycosylases by 2TX can result from two successive
molecular events: the reversible binding of the thiopurine
to the enzyme and the chemical reaction leading to (i) the
covalent linking of 2TX to C268 or C248 thiolates and (ii)
the Zn loss. Crystal structures of Fpg/DNA complexes in
the presence of 2TX showed unambiguously that the target
site of 2TX is localized outside the active site at the inter-
face between the H2TH and ZnF DNA binding domains
of the enzyme. It can be subdivided into at least one bind-
ing site and two reactive sites: W179 belonging to the helix
E of the H2TH motif and the most exposed C248/C268
of ZnF, respectively (Figure 2, Supplementary Figure S3).
Thus, the molecular mechanism for 2TX-mediated LlFpg
inhibition can be described by two steps: (step 1) 2TX se-
lectively binds to W179 and (step 2) reacts with C248 or
C268 thiolates which results in the Zn-coordination sphere
destabilization associated with the Zn release. As suggested
by structural and biochemical studies, this two-step mech-
anism can operate on the free (E) and DNA bound enzyme
(ES) (Figure 7).
Considering the polar character of 2TX (associated with
a strong negative electrostatic potential around the thione
function, (42)), the positively charged surface of the Zn-
coordination sphere (defined by the basic residues R247 and
K182) is clearly favorable to the approach and to the elec-
trostatic interaction of 2TX to its binding site. The stabi-
lization of the interaction relies next on the -orbital stack-
ing between the imidazole ring of 2TX and the indole ring
of W179 reinforced by the H-bond between the N(9)H of
2TX and the carbonyl of W179 (Figure 2f). Through bind-
ing to W179, 2TX replaces R247 which initially stacks to
W179 and contacts the ZnF cysteine thiolates by form-
ing two hydrogen bonds between its side chain and the S
atom of C268 and one hydrogen bond between its NH main
chain and the S atom of C245 in the ZnF native structure.
Residues W179 and R247 are clearly involved in the sec-
ond shell of the Zn-coordination sphere of LlFpg by es-
tablishing NH––S hydrogen bonds (from residue backbone
and/or basic side chain with Cysteine thiolates) (Supple-
mentary Table S3, Figure 7). Both experimental and theo-
retical studies show that such interactions tend to suppress
and/or significantly decrease the inherent reactivity of Zn-
bound thiolates in ‘structural’ ZnFs (especially those with 4
cysteines) by decreasing the apparent negative charge of the
ZnF core (57–59). For example, one intramolecular NH––S
hydrogen bond can decrease the rate of thiolate-alkylation
more than 30 times (60,61). Thus, a comparison between the
structures of native and oxidized ZnF suggests that the first
effect associated with the binding of 2TX to W179 is prob-
ably the increase in the nucleophilicity of ZnF-thiolates by
disrupting thiolate ligand interactions such as those medi-
ated by R247. In both structures obtained in the presence of
2TX, R247 has been displaced (Supplementary Figure S3).
If we assume that the reversible binding of 2TX is achieved
in this way (Step 1, Figure 7), W179 appears to be a key
residue for the binding of 2TX to LlFpg. This assumption
is also supported by the observation that all ZnF-Fpg/Nei
DNA glycosylases have an aromatic residue at the position
of W179 in E of their H2TH motifs (W, Y and F for LlFpg,
hNEIL2 and hNEIL3, respectively) (Supplementary Figure
S1d). Thus, the binding of 2TX to this conserved aromatic
residue of the H2TH motif can be directly connected to
the ability of the thiopurine to inhibit all ZnF-containing
Fpg/Nei DNA glycosylases. In a second step (Step 2, Fig-
ure 7), the precise binding mode of 2TX to W179 leads to
exquisitely expose the thio (thione/thiolate) group of 2TX
to the the ZnF activated thiolates of C268 and C248. Be-
cause of their vicinity, both sulfur atoms are readily oxidized
in the intermolecular disulfide bond observed in the crys-
tal structures according to a thiolate/disulfide interchange
mechanism. Such an oxidation of the free 2TX molecule in
its dimeric disulfide form without Fpg is strongly disadvan-
taged due to the stability of its thione tautomer which pre-
dominates in aqueous solution. Through binding to Fpg,
2TX can also be activated by shifting from its stable thione
to its active thiolate tautomer as has been observed for
mercaptobenzimadazole absorption onto gold nanoparti-
cles (62) (2TX-S*, Figure 7). At the same time, the thio-
late oxidation destabilizes the Zn-coordination sphere and
finally results in the loss of Zn ion and the formation of
an intra-disulfide bond between the most buried C245 and
C265 (E*I or E*SI, Figure 7).
At this stage of our knowledge, the precise redox chem-
istry of the ZnF oxidation by 2TX remains to be eluci-
dated and does not exclude other possible oxidation prod-
ucts after the loss of zinc whose nature strongly depends
on the redox potential of the medium. It is possible that,
before its release, the Zn2+ ion could also play a role in
this redox reaction. From this point of view, it is interest-
ing to note that a strong reducer power (1 mM of tris(2-
carboxyethyl)phosphine, TCEP, present in the stock Fpg
solution) does not prevent the oxidation of Fpg ZnF by 2TX
in the crystal structures nor in solution. A similar conclu-
sion can be drawn when 2TX-induced zinc release is ana-
lyzed in the presence of an excess of various thio-reducers
such as -mercaptoethanol (-SH), dithiothreitol (DTT)
and reduced glutathion (GSH) (Supplementary Figure S6).
As expected, reducers do not affect the structural integrity
of Fpg ZnF followed by the PAR assay (lanes 3, 4, 7, 8, 11
and 12, Supplementary Figure S6a). This is not surprising
since such reducers are often used in Fpg stock buffers and
known to protect the enzyme from oxidation. Interestingly,
the presence of thio-reducers in a 1/1 molar ratio with 2TX
(10 mM/10 mM against 5 M of LlFpg) partially protects
the enzyme by decreasing the apparent Zn-release velocity
(by about 1.5–2 times, Supplementary Figure S6b) without,
however, abolishing 2TX-induced oxidation process. This
experiment clearly confirmed the oxidative action of 2TX
on the enzyme. Thus, 2TX is able to attack Zn-sulfur coor-
dination bonds of ZnF-Fpg also in the presence of GSH, the
major redox form of glutathione in normal cellular condi-
tions. This result is consistent with the observation that 2TX
can operate in cellulo by significantly inhibiting the 5-OHC-
DNA glycosylase activity partly associated with hNEIL2
(Figure 6).
In order to test the molecular mechanism for inhibition
proposed in Figure 7, the key residues of LlFpg suspected to
play a role in 2TX-mediated inhibition in our 3D structures
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Figure 7. Molecular mechanism for 2TX-induced Fpg ZnF oxidation. Although kinetic inhibition of the enzyme (E) revealed that 2TX (I, in magenta) acts
mostly as an uncompetitive inhibitor (binding of the inhibitor to the enzyme/substrate complex, ES), PAR assay and EMSA unambiguously demonstrated
that 2TX is able to induce the release of Zn2+ ion from the free enzyme (a non-competitive inhibition behavior) (see text). Thus, the proposed molecular
mechanism assumes that in a first step, (I) can bind both E and ES to form EI or ESI transient complexes. Through specific binding (-orbital stacking and
one H-bond formation with W179), 2TX displaces R247 which results in the activation of C248 and C268 thiolates and its thione-function activation (S*,
in cyan). The transient complex (EI and ESI), readily and irreversibly leads to the inactivated enzyme complex (E*-I and E*S-I) in which the enzyme has
lost its Zn2+ ion (E*). Only the structures of (E*S-I) observed in the crystal structures of LlFpg/DNA complex-treated by 2TX are shown schematically
in the figure. For more details, see the text.
were targeted by site-directed mutagenesis. Four LlFpg
variants were constructed: W179A, R247G, C248GH and
C268H. The aim of constructing these point mutations was
to (i) disrupt the 2TX binding site (W179A), (ii) increase
the C268 thiolate reactivity (R247G) or (iii)inactivate the
reactive sites C248 or C268 by replacing C to H (C248GH,
which mimics the situation found in hNEIL2, Supplemen-
tary Figure S1c; C268H). Whereas all variants appear func-
tional in vivo by complementing the mutator phenotype of
the E. coli fpg− strain (Supplementary Figure S7a), only
R247G and C248GH could be overproduced in E. coli, pu-
rified to homogeneity and characterized structurally and
functionally. The crystal structures of R247G and C248GH
bound to 14-mer THF-DNA have been solved and indicate
that these point mutations do not affect the overall struc-
ture of ZnF as compared to the wild-type enzyme (Supple-
mentary Figure S7b,c, Supplementary Tables S2 and S3).
To evaluate the 2TX sensitivity of R247G and C248GH,
we used the PAR assay (Table 1). 2TX is able to extract the
zinc ion from ZnF of R247G 3-times faster than it does with
the wild-type enzyme. Assuming that the PAR assay is an-
other manner to estimate the inhibition efficiency of the en-
zyme (Figure 5), the variant R247G appears more sensitive
than the wild-type enzyme. As expected by 3D structures,
the suppression of NH––S bonds from the second coordi-
nation shell of ZnF increases the reactivity of ZnF thiolates
in the variant R247G and probably also the accessibility to
W179 for binding (Supplementary Table S2). In contrast,
the variant C248GH appears about two times less sensitive
to 2TX than the wild type (Table 1). As seen in the crystal
structure of [WT/THF]-2TX (Figure 2b), this suggests that
C248 is one of the reactive targets of 2TX but not the only
one since C248GH remains sensitive to 2TX. This result is
in perfect agreement with the crystal structure of [WT/Bz]-
2TX (Figure 2c) showing that C268 is another reactive tar-
get for 2TX and with the observation that hNEIL2 con-
taining CHC2 type of ZnF (Supplementary Figure S1c) is
also inhibited by 2TX (Figure 5, Table 1). Biochemical and
structural experiments combined with site-directed mutage-
nesis strongly support the proposed molecular mechanism
by which Fpg and the other ZnF-containing Fpg/Nei DNA
glycosylases are inhibited by 2TX (Figure 7). In this mech-
anism, the chemical reactivity of 2TX results from its pe-
culiar interaction with its enzyme binding site (conserved
aromatic site), whereas the free molecule in solution can
be considered hardly reactive in its major oxothione tau-
tomer (Figure 1a). This molecular mechanism is very differ-
ent from the one proposed for the inhibition of Myelopex-
oxidase (MPO, an enzyme involved in oxidative stress dur-
ing inflammation) by 2TX and its N3-alkylated-derivatives
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(63,64). In this case, the inhibition leads to the oxidation of
the drug resulting in a covalent adduct between the sulfur
atom of 2TX and the enzyme heme prosthestic group by fol-
lowing a complex radical chemistry used naturally by MPO
to oxidize several of its substrates (here and differently from
our case, 2TX-derivatives mimic true substrates). In this last
case, it was also proposed that the thio-tautomer nature of
the 2TX-derivatives determines their interaction with MPO
and thus their reactivity against the enzyme.
CONCLUSION
Because of the cancer therapeutic potential, the search for
DNA glycosylase inhibitors is a very active field mainly fo-
cused on the discovery of small molecules expected to mimic
the substrate by binding in the enzyme active site or at an
allosteric site preventing the removing of the damage base
(competitive inhibitors). In this work, we deciphered at the
atomic level the structural and/or functional determinants
required for the specific inhibition of ZnF Fpg/Nei DNA
glycosylases by the uncompetitive inhibitor 2TX. 3D struc-
tures revealed that after its specific binding 2TX reacts with
the enzyme by inducing the oxidation of ZnF which results
in an irreversible inhibition associated with the loss of zinc
ion. This study exemplifies that the special ZnF of Fpg/Nei
DNA glycosylases can been seen as selective template for
small ligand reactivity as it has been proposed for other ZnF
proteins (65). Overall, the data presented herein highlight
the structural and functional determinants for inhibition
and establish a foundation for the rational design of new
and more effective 2TX-derivatives taking into account the
electrostatic and steric constraints highlighted by 3D struc-
tures. Contrary to competitive inhibitors characterized to
date for DNA glycosylases (66–69), the interest of 2TX re-
sides in its ability to target both the free enzymes and the
enzymes bound to DNA (searching their substrates) and
in the irreversible character of inhibition. Furthermore, the
possibility of inhibiting a cell-cycle regulated DNA glyco-
sylase such as hNEIL3 (a ZnF-Fpg/Nei DNA glycosylase,
Supplementary Figure S1c) that is required in proliferating
cells appears promising for future medicinal chemistry de-
velopment in cancer therapy strategies. Since 2TX works
on Fpg/Nei DNA glycosylases in cellulo without apparent
toxicity, it will now be important to evaluate its selectivity
(and that of its future derivatives) by studying its potential
action on other Zn finger proteins and DNA glycosylases
from other structural superfamilies.
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